MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202647095908 A) filed by Shanghai Huilun Pharmaceutical Co. , Ltd. on August 07, 2026, for Novel Sodium Channel Modulator Compound And Use Thereof.
Inventors include Duan, Shudong; Du, Shuqi; and Qin, Jihong.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: Provided are a novel sodium channel modulator compound and a use thereof. The sodium channel modulator has a completely new structure as shown in formula I, and exhibits excellent in vitro inhibitory effects against Nav 1.8. The compound or a pharmaceutically acceptable salt thereof can be used for treating sodium channel- related diseases, including diseases such as pain, multiple sclerosis, Charcot-Marie-Tooth disease, incontinence, pathological cough, or arrhythmia.
Disclaimer: Curated by HT Syndication.
